Improvement of coronary vasodilatation capacity through single LDL apheresis (Q47702903)

4 February 2018

title

Improvement of coronary vasodilatation capacity through single LDL apheresis (English)

1 reference

4 February 2018

0 references

Mellwig KP

1

1 reference

4 February 2018

Baller D

2

1 reference

4 February 2018

Gleichmann U

3

1 reference

4 February 2018

Moll D

4

1 reference

4 February 2018

Betker S

5

1 reference

4 February 2018

Weise R

6

1 reference

4 February 2018

Notohamiprodjo G

7

1 reference

4 February 2018

publication date

1 July 1998

1 reference

4 February 2018

published in

Atherosclerosis

1 reference

4 February 2018

volume

139

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

173-178

1 reference

4 February 2018

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

Noninvasive quantification of regional blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

The significance of coronary reserve in clinical heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

A critical look at currently used indirect indices of myocardial oxygen consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

Hypercholesterolemia increases endothelial superoxide anion production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

Decreased low-density lipoprotein oxidation after repeated selective apheresis in homozygous familial hypercholesterolemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

[Acute effects of extracorporeal LDL cholesterol and fibrinogen elimination on blood rheology and microcirculation]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

Long-term intermittent urokinase therapy in patients with end-stage coronary artery disease and refractory angina pectoris: a randomized dose-response trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2898%2900055-0

10.1016/S0021-9150(98)00055-0

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018